Literature DB >> 17098629

Disseminated histoplasmosis: case report and brief review.

Abdulrahman Doughan1.   

Abstract

Disseminated Histoplasmosis is a severe and often-fatal opportunistic infection when left untreated among patients with AIDS. Occurring in 3-5 percent of patients with AIDS living in the areas of endemicity, this infection should be suspected in patients with a CD4 cell count of <150 cells/microL presenting with non-specific clinical signs such as fever, weight loss, and lymphadenopathy. We report our experience to increase awareness of the clinical spectrum of disseminated histoplasmosis and its similarity to other infections and malignancies and update the reader on recommended therapeutic modalities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098629     DOI: 10.1016/j.tmaid.2006.01.013

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  5 in total

1.  Disseminated histoplasmosis presenting as a case of erythema nodosum and hemophagocytic lymphohistiocytosis.

Authors:  Tanushri Mukherjee; Atoshi Basu
Journal:  Med J Armed Forces India       Date:  2015-03-29

2.  Progressive disseminated histoplasmosis in idiopathic CD4 lymphocytopenia an underdiagnosed combination - a case report.

Authors:  Prakrati Yadav; Deepak Kumar; Gopal Krishna Bohra; Mahendra Kumar Garg; Jyotsna N Bharti; Abhishek Hl Purohit; Durga Shankar Meena
Journal:  Med Pharm Rep       Date:  2022-04-28

3.  Disseminated histoplasmosis in an immunocompetent patient from an endemic area: A case report.

Authors:  Qingxia Ling; Weishan Zhu; Qun Lu; Ting Jin; Shenhua Ding
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

4.  A Case of Histoplasmosis Mimicking Primary Lung Cancer With Liver Metastasis.

Authors:  Emmanuel Fohle; Rishi Seth; Abhishek Matta
Journal:  Cureus       Date:  2021-02-23

5.  An exuberant form of disseminated histoplasmosis.

Authors:  Débora Mânica Rockenbach; Lia Natalia Diehl Dallazem; Raíssa Londero Chemello; André Avelino Costa Beber
Journal:  Braz J Infect Dis       Date:  2018-06-22       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.